Publication:
Cell therapy and delivery strategies for spinal cord injury

Thumbnail Image
Files
Ramalho-36-907-920-2021.pdf(2.68 MB)
Date
2021
relationships.isAuthorOfPublication
relationships.isSecondaryAuthorOf
relationships.isDirectorOf
Authors
Ramalho, Bruna dos S. ; de Almeida, Fernanda M. ; Martinez, Ana M.B.
item.page.secondaryauthor
item.page.director
Publisher
Universidad de Murcia, Departamento de Biologia Celular e Histiologia
publication.page.editor
publication.page.department
DOI
https://doi.org/10.14670/HH-18-350
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Spinal cord injury (SCI) is a complex neuropathological condition that represents a major challenge for clinicians and scientists due to patient's functional dysfunction and paralysis. Several treatments have been proposed including biological factors, drugs and cells administered in various ways. Stem cells arise as good candidates to treat SCI since they are known to secrete neurotrophic factors, improving neuroregeneration, but also due to their role in modulating the inflammatory process, favoring a pro-regenerative status. There are several types of cells that have been tested to treat SCI in experimental and clinical studies, but we still face many unanswered questions; one of them is the type of cells that can offer the best benefits and, also the ideal dose and administration routes. This review aimed to summarize recent research on cell treatment, focusing on current delivery strategies for SCI therapy and their effects in tissue repair and regeneration.
publication.page.subject
Spinal cord injury , Cell transplantation , Delivery routes
Citation
Histology and Histopathology Vol. 36, nº9 (2021)
URI
http://hdl.handle.net/10201/127748
item.page.embargo
Collections
Histology and histopathology Vol.36, nº9 (2021)
Ir a Estadísticas